Related Experiment Video
Updated: Mar 7, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers
Thomas Efferth1, Manfred Volm2
1Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany. efferth@uni-mainz.de.
Abstract:
The detoxification of toxic substances is of general relevance in all biological systems. The plethora of exogenous xenobiotic compounds and endogenous toxic metabolic products explains the evolutionary pressure of all organisms to develop molecular mechanisms to detoxify and excrete harmful substances from the body. P-glycoprotein and other members of the ATP-binding cassette (ABC) transporter family extrude innumerous chemical compounds out of cells. Their specific expression in diverse biological contexts cause different phenotypes: (1) multidrug resistance (MDR) and thus failure of cancer chemotherapy, (2) avoidance of accumulation of carcinogens and prevention of carcinogenesis in healthy tissues, (3) absorption, distribution, metabolization and excretion (ADME) of pharmacological drugs in human patients, (4) protection from environmental toxins in aquatic organisms (multi-xenobiotic resistance, MXR). Hence ABC-transporters may have opposing effects for organismic health reaching from harmful in MDR of tumors to beneficial for maintenance of health in MXR. While their inhibition by specific inhibitors may improve treatment success in oncology and avoid carcinogenesis, blocking of ABC-transporter-driven efflux by environmental pollutants leads to ecotoxicological consequences in marine biotopes. Poisoned seafood may enter the food-chain and cause intoxications in human beings. As exemplified with ABC-transporters, joining forces in interdisciplinary research may, therefore, be a wise strategy to fight problems in human medicine and environmental sciences.
Insights
ATP-binding cassette (ABC) transporters detoxify harmful substances, but their roles vary. While crucial for health, they can cause multidrug resistance in cancer and environmental toxicity.
Area of Science:
- Biochemistry
- Environmental Science
- Pharmacology
Background:
- Organisms possess molecular mechanisms to detoxify and excrete harmful xenobiotics and endogenous toxins.
- ATP-binding cassette (ABC) transporters are key players in extruding diverse chemical compounds from cells.
- These transporters are vital for cellular defense and maintaining health across species.
Purpose of the Study:
- To explore the dual role of ABC transporters in biological systems.
- To highlight their impact on human health, cancer therapy, and environmental toxicology.
- To emphasize the need for interdisciplinary research in medicine and environmental science.
Main Methods:
- Review of existing literature on ABC transporter functions.
- Analysis of phenotypes associated with ABC transporter expression, including multidrug resistance (MDR) and multi-xenobiotic resistance (MXR).
- Examination of the implications of ABC transporter activity in cancer chemotherapy and ecotoxicology.
Main Results:
- ABC transporters exhibit context-dependent effects, leading to beneficial outcomes like carcinogenesis prevention and harmful effects like MDR in tumors.
- Their activity influences drug absorption, distribution, metabolism, and excretion (ADME) in humans.
- Inhibition of ABC transporters can aid cancer treatment but blocking their efflux function by pollutants causes ecotoxicity and potential food chain contamination.
Conclusions:
- ABC transporters play a critical, albeit complex, role in detoxification and cellular protection.
- Understanding their multifaceted functions is essential for both human medicine and environmental protection.
- Interdisciplinary collaboration is crucial to address challenges related to ABC transporters in health and the environment.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drug Metabolism: Phase II Reactions
Phase II Reactions: Glucuronidation

